Evidence map›Paper›PMID 19251721›Full record

ReviewCardiovascular research2009

Myocardial protection by nitrite.

John W Calvert, David J Lefer

Open access · bronzeAbstract readReview
In one paragraph

Review in Cardiovascular research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 82 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Nitric oxide delivery using nitric oxide-containing fluid in continuous hemofiltration: an in vitro study.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Nitrite reduction by molybdoenzymes: a new class of nitric oxide-forming nitrite reductases.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2015
    Review
  14. Review
  15. Article
  16. Nitrite in organ protection.British journal of pharmacology · 2014
    Review
  17. Article
  18. Article
  19. Nitrite as Direct S-Nitrosylating Agent of Kir2.1 Channels.International scholarly research notices · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

John W CalvertDepartment of Surgery, Division of Cardiothoracic Surgery, Emory University School of Medicine, Carlyle Fraser Heart Center Crawford Long Hospital, 6th Floor Medical Office Tower, 550 Peachtree Street NE, Atlanta, GA 30308-2247, USA.
David J Lefer
Emory University Hospital Midtown · US

Funding

MECHANISMS OF MYOCARDIAL REPERFUSION INJURY IN DIABETESR01HL060849 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI LEFER, DAVID JOSEPH · 1999 to 2008
$1.5M
Mechanisms of Nitrite Mediated Hepatic Preconditioning: Role of the MitochondriaF32DK077380 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI CALVERT, JOHN WINTER · 2006 to 2008
$74k
NHLBI NIH HHS 2 R01 HL-060849-09NIDDK NIH HHS F32 DK 077380-01
6 · The paper itself

Abstract

Nitrite has long been considered to be an inert oxidative metabolite of nitric oxide (NO). Recent work, however, has demonstrated that nitrite represents an important tissue storage form of NO that can be reduced to NO during ischaemic or hypoxic events. This exciting series of discoveries has created an entirely new field of research that involves the investigation of the molecular, biochemical, and physiological activities of nitrite under a variety of physiological and pathophysiological states. This has also led to a re-evaluation of the role that nitrite plays in health and disease. As a result there has been an interest in the use of nitrite as a therapeutic strategy for the treatment of acute myocardial infarction. Nitrite therapy has now been studied in several animal models and has proven to be an effective means to reduce myocardial ischaemia-reperfusion injury. This review article will provide a brief summary of the key findings that have led to the re-evaluation of nitrite and highlight the evidence supporting the cardioprotective actions of nitrite and also highlight the potential clinical application of nitrite therapy to cardiovascular diseases.

Indexed as

AnimalsCytoprotectionHomeostasisHumansMyocardial InfarctionMyocardial Reperfusion InjuryMyocardiumNitric OxideNitritesRisk FactorsTreatment OutcomeNitric OxideNitrites

Identifiers

PMID19251721
PMCPMC2701719
OpenAlexW1978288131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.